C4 Therapeutics (CCCC)
(Delayed Data from NSDQ)
$5.38 USD
+0.04 (0.75%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $5.23 -0.15 (-2.79%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth B Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/6/24 |
---|---|
Current Quarter | -0.40 |
EPS Last Quarter | -0.26 |
Last EPS Surprise | 29.73% |
ABR | 1.75 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.57 |
Next Year | -1.62 |
EPS (TTM) | -1.90 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 5.95M | 7.33M | 25.66M | 26.70M |
# of Estimates | 4 | 4 | 5 | 3 |
High Estimate | 8.40M | 11.60M | 34.30M | 30.00M |
Low Estimate | 3.00M | 2.00M | 15.00M | 20.40M |
Year ago Sales | 11.07M | 3.26M | 20.76M | 25.66M |
Year over Year Growth Est. | -46.23% | 124.69% | 23.62% | 4.06% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.40 | -0.43 | -1.57 | -1.62 |
# of Estimates | 5 | 5 | 4 | 5 |
Most Recent Consensus | -0.46 | -0.46 | -1.59 | -1.90 |
High Estimate | -0.28 | -0.27 | -1.46 | -1.38 |
Low Estimate | -0.46 | -0.64 | -1.70 | -1.90 |
Year ago EPS | -0.55 | -0.68 | -2.67 | -1.57 |
Year over Year Growth Est. | 27.27% | 36.76% | 41.20% | -3.22% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 1 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.40 | -0.43 | -1.57 | -1.62 |
7 Days Ago | -0.40 | -0.43 | -1.57 | -1.62 |
30 Days Ago | -0.40 | -0.43 | -1.57 | -1.62 |
60 Days Ago | -0.40 | -0.40 | -1.57 | -1.62 |
90 Days Ago | -0.37 | -0.44 | -1.70 | -1.82 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.40 | -0.43 | -1.57 | -1.62 |
Zacks Consensus Estimate | -0.40 | -0.43 | -1.57 | -1.62 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.26 | -0.41 | -0.68 | -0.55 | NA |
Estimate | -0.37 | -0.41 | -0.67 | -0.65 | NA |
Difference | 0.11 | 0.00 | -0.01 | 0.10 | 0.05 |
Surprise | 29.73% | 0.00% | -1.49% | 15.38% | 10.91% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more